Skip to content

Cardiovascular Disease Population Risk Tool

Risk of Cardiovascular Disease in Canada and Burden of Health Behaviours: Development of Population-based Risk Algorithms

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02267447
Acronym
CVDPoRT
Enrollment
104219
Registered
2014-10-17
Start date
2000-09-30
Completion date
2016-04-30
Last updated
2017-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Diseases

Keywords

Cardiovascular diseases, Clinical prediction rule, Population projection, Risk stratification, Health behavior

Brief summary

The purpose of this study is to develop, evaluate, and apply a predictive algorithm for assessing CVD risk in the community setting: the Cardiovascular Disease Population Risk Tool (CVDPoRT).

Detailed description

This observational study will use the Ontario sample of the Canadian Community Health Survey (2001, 2003, 2005; 77,251 respondents) to assess risk factors - focusing on health behaviours (physical activity, diet, smoking, and alcohol use). Incident CVD outcomes will be assessed through linkage to administrative healthcare databases (619,886 person-years of follow-up until 31 December 2011). Socio-demographic factors (age, sex, immigrant status, education) and mediating factors such as presence of diabetes and hypertension will be included as predictors. Risk prediction models will be developed using competing risks survival analysis. The analysis plan adheres to published recommendations for the development of valid risk prediction models to limit the risk of over-fitting and improve the quality of predictions. Key considerations are fully pre-specifying the predictor variables; appropriate handling of missing data; use of flexible functions for continuous predictors; and avoiding data-driven variable selection procedures that increase the risk of type I error. The 2007 and 2009 surveys (approximately 50,000 respondents) will be used for validation. Calibration will be assessed overall and in predefined subgroups of importance to clinicians and policymakers.

Interventions

None listed

Sponsors

Canadian Institutes of Health Research (CIHR)
CollaboratorOTHER_GOV
Institute for Clinical Evaluative Sciences
CollaboratorOTHER
Statistics Canada
CollaboratorUNKNOWN
Ottawa Hospital Research Institute
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Respondents to the Canadian Community Health Surveys

Exclusion criteria

* Not eligible for Ontario's universal health insurance program * Pregnant * Prior history of heart disease or stroke * Younger than age 20

Design outcomes

Primary

MeasureTime frameDescription
Major Cardiovascular Disease Eventup to 12 yearsThe primary outcome of interest was a major CVD event resulting in hospitalization or sudden death from CVD. Respondents were followed from the survey administration date until the earliest of: incident event, death due to causes other than CVD (defined as a competing risk), loss to follow-up (defined as loss of health care eligibility), or end of study (31 December 2012).

Other

MeasureTime frame
Death Due to Causes Other Than CVDup to 12 years

Participant flow

Participants by arm

ArmCount
Derivation Cohort
Eligible respondents to the combined 2001, 2003 and 2005 Canadian Community Health Surveys, conducted by Statistics Canada.
77
Validation Cohort
Eligible respondents to the 2007/2008 Canadian Community Health Survey.
26
Total103

Baseline characteristics

CharacteristicDerivation CohortValidation CohortTotal
Age, Continuous
Female
48.0 years51.0 years49.5 years
Age, Continuous
Male
46.0 years48.0 years47.0 years
Sex: Female, Male
Female
42185 Participants14801 Participants56986 Participants
Sex: Female, Male
Male
35066 Participants12167 Participants47233 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 00 / 0
serious
Total, serious adverse events
0 / 00 / 0

Outcome results

Primary

Major Cardiovascular Disease Event

The primary outcome of interest was a major CVD event resulting in hospitalization or sudden death from CVD. Respondents were followed from the survey administration date until the earliest of: incident event, death due to causes other than CVD (defined as a competing risk), loss to follow-up (defined as loss of health care eligibility), or end of study (31 December 2012).

Time frame: up to 12 years

ArmMeasureValue (NUMBER)
Derivation CohortMajor Cardiovascular Disease Event3182 Cardiovascular disease event
Validation CohortMajor Cardiovascular Disease Event527 Cardiovascular disease event
Other Pre-specified

Death Due to Causes Other Than CVD

Time frame: up to 12 years

ArmMeasureValue (NUMBER)
Derivation CohortDeath Due to Causes Other Than CVD3538 deaths
Validation CohortDeath Due to Causes Other Than CVD979 deaths

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026